Cidara Therapeutics, Inc.

Direct answer

Cidara Therapeutics, Inc. is publicly traded on NASDAQ under the ticker CDTX.

Cidara Therapeutics, Inc. is a biotechnology company specializing in the creation, advancement, and commercialization of extended-duration anti-infective drugs. Their mission targets the prevention and treatment of infectious diseases and certain cancers within the U.S. Their primary therapeutic candidate, rezafungin acetate, is an innovative echinocandin antifungal designed to combat and avert severe fungal...

Can you invest in Cidara Therapeutics, Inc.?

Yes. Cidara Therapeutics, Inc. is publicly traded on NASDAQ under the ticker CDTX.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Cidara Therapeutics, Inc.

Detailed equity research is provided by MarketSnap.